A group of former Motorola workers and their children filed a lawsuit Friday against the Schaumburg-based company, claiming toxic substances used to make Motorola products caused serious birth defects in at least 30 children born to workers employed by the company since the 1960s. The 71 plaintiffs filed the suit…
A lawsuit has been filed against the Arizona Board of Regents by a former Arizona State student who claims that the university police department and disciplinary office failed to properly investigate her accusations that she was raped. According to the police report, the woman reported the alleged incident the day…
GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements. The settlements, which provide an average payout of more than $1.2 million to families of affected…
A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files. Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The…
In 2005, the Food and Drug Administration (FDA) warned doctors about a study showing that babies born to women who took Paxil during the first trimester of pregnancy had a higher rate of major birth defects. The study, which involved 3,500 pregnant women, showed that those on Paxil were twice…
A lawsuit was filed against two northern railroad companies this week by the family of a Chicago woman who was hit by a train and killed. Katie Ann Lunn died in the train accident earlier this year when an Amtrak train hit her SUV, which was stopped on the tracks…
In treating diabetes, it might not matter much whether the Food and Drug Administration halts sales of the drug Avandia. An FDA committee of outside experts met last week to provide advice on whether any regulatory action — from stronger warnings to removal — is needed. The FDA has the…
The New York Times (7/16, B2, Jolly, Harris) reports that UK pharmaceutical maker GlaxoSmithKline announced on July 15 that “it would take a second-quarter charge of $2.36 billion related to legal cases involving its drugs Avandia [rosiglitazone] and Paxil [paroxetine].” This announcement comes one “day after an American medical advisory…
A Texas natural gas producer’s decision to voluntarily disclose the chemicals it injects into the ground could prompt other drillers to do the same, and pave the way for regulators to require such disclosure. But Range Resources Corp.’s move also reflects the desire of industry to get out ahead of…
An FDA panel has made a recommendation to the agency that the controversial diabetes drug Avandia should either be taken off the market or its sales should be severely restricted. Avandia and its maker, GlaxoSmithKline, have recently come under fire for trial results that reveal that patients taking Avandia are…